Show simple item record

dc.contributor.authorDrebber, U.
dc.contributor.authorManns, M. P.
dc.contributor.authorBozkaya, H.
dc.contributor.authorMeyer, S.
dc.contributor.authorDienes, H. P.
dc.contributor.authorWedemeyer, H.
dc.contributor.authorYurdaydin, C.
dc.contributor.authorDalekos, G.
dc.contributor.authorErhardt, A.
dc.contributor.authorCakaloglu, Y.
dc.contributor.authorDegertekin, H.
dc.contributor.authorGurel, S.
dc.contributor.authorZeuzem, S.
dc.contributor.authorBock, T.
dc.contributor.authorZachou, K.
dc.date.accessioned2021-03-04T13:06:15Z
dc.date.available2021-03-04T13:06:15Z
dc.identifier.citationWedemeyer H., Yurdaydin C., Dalekos G., Erhardt A., Cakaloglu Y., Degertekin H., Gurel S., Zeuzem S., Bock T., Zachou K., et al., "72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis", 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, İspanya, 11 - 15 Nisan 2007, cilt.46
dc.identifier.othervv_1032021
dc.identifier.otherav_7a9d34f9-61b3-48bb-b9df-241a31214087
dc.identifier.urihttp://hdl.handle.net/20.500.12627/84000
dc.identifier.urihttps://doi.org/10.1016/s0168-8278(07)61602-x
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.title72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume46
dc.contributor.firstauthorID133652


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record